Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for amphotericin root_references_citation in Reference Text / Citation (approximate match)

Showing 1031 - 1040 of 1270 results

First page
Previous page
Next page
Next page

POLYETHYLENE OXIDE 2000000

5K3991GVWI

Status:

Possibly Marketed Outside US

Source:

M032

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10d146c2-7108-43c0-9f10-726d14cc9433

First approved in 1985

Source:

NDA022497

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a032e7c8-33f2-5fdb-62d7-8517072d1d10

Class:

POLYMER

AMMONIO METHACRYLATE COPOLYMER TYPE B

161H3B14U2

Status:

Possibly Marketed Outside US

Source:

ANDA074093

(1992)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51abce7b-e3d1-44b5-bccc-d463150d0bba

First approved in 1976

Source:

NDA020353

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9225acaa-209f-958b-2c51-9a46995dec33

Class:

POLYMER

POLYDEXTROSE

VH2XOU12IE

Status:

Possibly Marketed Outside US

Source:

M006

(2019)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5291f67-3329-42c7-b9c2-9bae797ecb5b

First approved in 1970

Source:

O-Cal FA multivitamin by Pharmics, Inc.

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b24458b-6d48-4cc6-8233-81f173277cb8

Class:

POLYMER

TISAGENLECLEUCEL

Q6C9WHR03O

Status:

US Approved Rx (2017)

Source:

BLA125646

(2017)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2017

Source:

BLA125646

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

SARS-COV2

B6L4N5Z4GH

Status:

Investigational

Source:

NCT04387760: Phase 2 Interventional Completed SARS-CoV 2

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04387760

Class:

STRUCTURALLY DIVERSE

PEXASTIMOGENE DEVACIREPVEC

K82DG47I0G

Status:

Investigational

Source:

NCT03294083: Phase 1/Phase 2 Interventional Active, not recruiting Renal Cell Carcinoma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03294083

Class:

STRUCTURALLY DIVERSE

MYCOBACTERIUM TUBERCULOSIS

R0EM8D5HFD

Status:

Investigational

Source:

NCT00397943: Phase 2 Interventional Completed Tuberculosis

(2006)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00397943

Class:

STRUCTURALLY DIVERSE

VIBRIO CHOLERAE STRAIN PERU 15

ZRR8MW9QZ5

Status:

Investigational

Source:

NCT00741637: Phase 2 Interventional Completed Cholera

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00741637

Class:

STRUCTURALLY DIVERSE

Plasmodium falciparum

536WV61NML

Status:

Investigational

Source:

NCT03867331: Phase 1 Interventional Completed Malaria,Falciparum

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03867331

Class:

STRUCTURALLY DIVERSE

HUMAN HERPESVIRUS 5

7COI029E6K

Status:

Investigational

Source:

NCT00693095: Phase 1 Interventional Completed Glioblastoma

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00693095

Class:

STRUCTURALLY DIVERSE

Structure of POLYETHYLENE OXIDE 2000000

Polymer

POLYETHYLENE OXIDE 2000000

Structure of AMMONIO METHACRYLATE COPOLYMER TYPE B

Polymer

AMMONIO METHACRYLATE COPOLYMER TYPE B

Structure of POLYDEXTROSE

Polymer

Structurally Diverse

TISAGENLECLEUCEL

Structurally Diverse

SARS-COV2

Structurally Diverse

PEXASTIMOGENE DEVACIREPVEC

Structurally Diverse

MYCOBACTERIUM TUBERCULOSIS

Structurally Diverse

VIBRIO CHOLERAE STRAIN PERU 15

Structurally Diverse

Plasmodium falciparum

Structurally Diverse

HUMAN HERPESVIRUS 5

Showing 1031 - 1040 of 1270 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1